Vimarsana
Biggest News Aggregation in the World

Page 23 - Webcast Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Webcast Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Webcast Information Today - Breaking & Trending Today

Precision Optics Reports Fourth Quarter and Fiscal Year 2023 Financial Results - Vimarsana News

Precision Optics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Precision Optics Corporation, Inc. , a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30,...

Precision Optics Reports Fourth Quarter and Fiscal Year 2023 Financial Results - Vimarsana News

Precision Optics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

/PRNewswire/ -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and...

American Oncology Network to Host Investor Presentation Webcast on September 29 - Vimarsana News

American Oncology Network to Host Investor Presentation Webcast on September 29

27.09.2023 - FORT MYERS, Fla., Sept. 27, 2023 (GLOBE NEWSWIRE) - American Oncology Network, Inc. (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices announced today that it will host an investor presentation ... Seite 1

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2023 Conference Call for Thursday, September 28, 2023 - Vimarsana News

Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2023 Conference Call for Thursday, September 28, 2023

/PRNewswire/ -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the...

Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients - Vimarsana News

Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients

IDE supported by data from the MODERATO II randomized pilot study that showed AVIM therapy drove significant and sustained reductions in blood pressure in hypertensive pacemaker patients